Schwab Andrew J. sold SKYE
August 20, 2026 · Form 4 insider transaction
Schwab Andrew J. sold 46 shares of Skye Bioscience, Inc. at $0.32 per share, a transaction worth $14.72. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
46
Price
$0.32
Total value
$14.72
InsiderSchwab Andrew J.
RoleDirector, 10% owner
CompanySkye Bioscience, Inc. (SKYE)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 20, 2026
Filing dateAugust 20, 2026
Shares owned after55,208
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The securities are directly held by 5AM Co-Investors II, L.P. ("Co-Investors II"). Partners II is the sole general partner of Co-Investors II. The Reporting Person is a managing member of Partners II and may be deemed to have shared voting and investment power over the shares beneficially owned by Co-Investors II. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.